Your browser doesn't support javascript.
loading
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.
Gladstone, R A; Siira, L; Brynildsrud, O B; Vestrheim, D F; Turner, P; Clarke, S C; Srifuengfung, S; Ford, R; Lehmann, D; Egorova, E; Voropaeva, E; Haraldsson, G; Kristinsson, K G; McGee, L; Breiman, R F; Bentley, S D; Sheppard, C L; Fry, N K; Corander, J; Toropainen, M; Steens, A.
Afiliación
  • Gladstone RA; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Siira L; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Brynildsrud OB; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Vestrheim DF; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Turner P; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia.
  • Clarke SC; Faculty of Medicine and Institute of Life Sciences, University of Southampton, UK; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Trust, Southampton, United Kingdom; Global Health Research Institute, University of Southampton, Southampton, United Kingdom; School of
  • Srifuengfung S; Faculty of Pharmacy, Siam University, Bangkok, Thailand.
  • Ford R; Papua New Guinea Institute of Medical Research, PO Box 60, Goroka 441, Eastern Highlands Province, Papua New Guinea.
  • Lehmann D; Telethon Kids Institute, the University of Western Australia, Perth, WA, Australia.
  • Egorova E; G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia.
  • Voropaeva E; G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia.
  • Haraldsson G; Department of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland.
  • Kristinsson KG; Department of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland.
  • McGee L; Centers for Disease Control and Prevention, Atlanta, USA.
  • Breiman RF; Emory Global Health Institute, Atlanta, USA; Rollins School Public Health, Emory University, USA.
  • Bentley SD; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Sheppard CL; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, London, United Kingdom.
  • Fry NK; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, London, United Kingdom; Immunisation and Countermeasures Division, Public Health England - National Infection Service, London, United Kingdom.
  • Corander J; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Toropainen M; Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Steens A; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Vaccine ; 40(7): 1054-1060, 2022 02 11.
Article en En | MEDLINE | ID: mdl-34996643

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article